4:05 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Neumora Therapeutics Nasdaq/NYSE Compliance Notice
Neumora Therapeutics received a deficiency notice from Nasdaq for failing to maintain the $1.00 minimum bid price requirement for its common stock. The company has 180 calendar days, until April 26, 2027, to regain compliance by having its stock close at $1.00 or higher for at least ten consecutive business days.
- Counterparty
- The Nasdaq Stock Market LLC
- Term
- 180 days